始于1953年,專注于化學制藥/維生素及營養保健品/現代中藥/生物農獸藥等領域,集研發/生產/服務于一體的現代化醫藥健康產業集團
華(hua)(hua)(hua)(hua)北(bei)(bei)(bei)(bei)制(zhi)(zhi)藥集(ji)團有(you)(you)限責(ze)(ze)任公(gong)(gong)司(簡稱:華(hua)(hua)(hua)(hua)藥集(ji)團)位于河(he)北(bei)(bei)(bei)(bei)省(sheng)省(sheng)會石(shi)家莊市(shi)。前(qian)身華(hua)(hua)(hua)(hua)北(bei)(bei)(bei)(bei)制(zhi)(zhi)藥廠是中(zhong)(zhong)國(guo)“一五”計劃期間的重點建設(she)項(xiang)目,1953年(nian)6月(yue)開始籌建,1958年(nian)6月(yue)建成投產,開創了我(wo)國(guo)大規模生(sheng)產抗生(sheng)素的歷史,為人類健康事(shi)業、民族制(zhi)(zhi)藥工業發展(zhan)和改變我(wo)國(guo)缺(que)醫少(shao)藥局(ju)面做出了重要(yao)貢獻。1992年(nian)重組(zu)設(she)立(li)華(hua)(hua)(hua)(hua)北(bei)(bei)(bei)(bei)制(zhi)(zhi)藥股(gu)份(fen)有(you)(you)限公(gong)(gong)司,1994年(nian)在(zai)上(shang)交所掛(gua)牌(pai)上(shang)市(shi)(股(gu)票名稱:華(hua)(hua)(hua)(hua)北(bei)(bei)(bei)(bei)制(zhi)(zhi)藥600812)。1996年(nian)1月(yue),華(hua)(hua)(hua)(hua)北(bei)(bei)(bei)(bei)制(zhi)(zhi)藥廠正式改制(zhi)(zhi)為國(guo)有(you)(you)獨資公(gong)(gong)司——華(hua)(hua)(hua)(hua)北(bei)(bei)(bei)(bei)制(zhi)(zhi)藥集(ji)團有(you)(you)限責(ze)(ze)任公(gong)(gong)司。2009年(nian)6月(yue),經河(he)北(bei)(bei)(bei)(bei)省(sheng)政(zheng)府批準,冀中(zhong)(zhong)能源集(ji)團對華(hua)(hua)(hua)(hua)藥集(ji)團實施了重組(zu)。
多年來,華(hua)藥(yao)集團(tuan)秉承(cheng)“人類健(jian)(jian)康至上,質量永(yong)遠第一”的企業宗(zong)旨,持續(xu)創(chuang)新,穩健(jian)(jian)經(jing)營,逐步(bu)壯大,經(jing)營范圍不斷拓展,發展業績(ji)保持優(you)良,主(zhu)(zhu)要(yao)經(jing)濟技(ji)術指標(biao)始終(zhong)處于國(guo)內同行業前(qian)列。截至2018年底,華(hua)藥(yao)集團(tuan)資產(chan)(chan)(chan)總額(e)206億元(yuan),職工近1.5萬(wan)人,擁(yong)有(you)(you)四(si)十(shi)多家子(分(fen))公司,擁(yong)有(you)(you)微生(sheng)(sheng)物(wu)藥(yao)物(wu)國(guo)家工程研(yan)究中(zhong)(zhong)心(xin)、抗體(ti)藥(yao)物(wu)研(yan)制(zhi)國(guo)家重(zhong)點實驗室(shi)、抗生(sheng)(sheng)素(su)酶催化與(yu)結晶技(ji)術國(guo)家地方聯(lian)合工程實驗室(shi)三(san)個創(chuang)新平臺,主(zhu)(zhu)要(yao)產(chan)(chan)(chan)品涉及(ji)化學制(zhi)藥(yao)、現(xian)代(dai)生(sheng)(sheng)物(wu)技(ji)術藥(yao)物(wu)、維生(sheng)(sheng)素(su)及(ji)營養保健(jian)(jian)品、現(xian)代(dai)中(zhong)(zhong)藥(yao)、生(sheng)(sheng)物(wu)農獸藥(yao)等領(ling)域近千(qian)個品規,治療領(ling)域涵(han)蓋抗感(gan)染類、心(xin)腦血管(guan)類、腎病(bing)、抗腫瘤及(ji)免疫調(diao)節類等,主(zhu)(zhu)要(yao)生(sheng)(sheng)產(chan)(chan)(chan)單元(yuan)的工藝路線、生(sheng)(sheng)產(chan)(chan)(chan)布(bu)局全部(bu)按照歐美現(xian)行版(ban)、中(zhong)(zhong)國(guo)新版(ban)GMP標(biao)準(zhun)設計實施,擁(yong)有(you)(you)具備國(guo)際(ji)領(ling)先水準(zhun)的現(xian)代(dai)化制(zhi)藥(yao)生(sheng)(sheng)產(chan)(chan)(chan)平臺。